Members |
targetComponentId |
Drainage of boil of skin NEC |
Drainage of boil of skin |
Drainage of cyst NEC |
Drainage procedure |
Drainage of cyst of pancreas into jejunum NEC |
Pancreaticocystojejunostomy |
Drainage of female perineal abscess |
Drainage of perineal abscess (procedure) |
Drainage of male periurethral abscess |
Drainage of periurethral abscess (procedure) |
Drainage of organ NOC |
Drainage procedure |
Drainage of organ NOC NOS |
Drainage procedure |
Draughtsman NOS |
Draughtsman |
Drechslera longirostrata |
Exserohilum longirostratum |
Dressing - action |
Application - action |
Dried factor IX fraction heated 600iu powder and solvent for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Dried factor IX fraction heated 600iu powder for conventional release solution for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Drilling of organ NOC |
Drilling |
Drimaren brilliant yellow |
Textile colours and finishes patch test substance |
Driving examination NOS |
Driving-related medical examination (procedure) |
Driving examination NOS |
Driving-related medical examination (procedure) |
Drop attacks in middle-aged woman |
Drop attack |
Drostanolone propionate allergy |
Allergy to drostanolone (finding) |
Drotrecogin alfa (activated) 5mg powder for infusion solution vial |
Drotrecogin alfa 5 mg powder for solution for injection vial |
Drotrecogin alfa 20mg powder for infusion solution vial |
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Drug |
Pharmaceutical / biologic product (product) |
Drug abuse in remission |
Harmful pattern of substance use in remission |
Drug addiction notif NOS |
Drug addiction notification status |
Drug addiction notif NOS |
Drug addiction notification |
Drug aerosol, 0,01% |
Drug aerosol |
Drug aerosol, 0,04% |
Drug aerosol |
Drug aerosol, 0,5% |
Drug aerosol |
Drug cream, 0,01% |
Cream |
Drug cream, 0,02% |
Cream |
Drug cream, 0,025% |
Cream |
Drug cream, 0,05% |
Cream |
Drug cream, 0,1% |
Cream |
Drug cream, 0,25% |
Cream |
Drug cream, 0,5% |
Cream |
Drug cream, 1% |
Cream |
Drug cream, 2,5% |
Cream |
Drug dependence |
Substance dependence (disorder) |
Drug dependence - unspecified whether during pregnancy or the puerperium |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
Drug dependence NOS |
Substance dependence (disorder) |
Drug dependence NOS |
Substance dependence (disorder) |
Drug dependence during childbirth, puerperium (& pregnancy) |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
Drug dependence during pregnancy, childbirth and the puerperium |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
Drug dependence during pregnancy, childbirth or the puerperium NOS |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
Drug dependence in childbirth |
Substance dependence in childbirth |
Drug dependence in mother complicating pregnancy, childbirth AND/OR puerperium |
Substance dependence in mother complicating pregnancy, childbirth and/or puerperium (disorder) |
Drug dependence in remission |
Substance dependence in remission |
Drug dependence, continuous |
Substance dependence, continuous |
Drug dependence, episodic |
Substance dependence, episodic (disorder) |
Drug for supraventricular arrhythmia |
Antiarrhythmic agent (substance) |
Drug for ventricular arrhythmia |
Antiarrhythmic agent (substance) |
Drug gel, 0,05% |
Gel |
Drug gel, 0,1% |
Gel |
Drug gel, 0,25% |
Gel |
Drug groups and agents primarily acting on skin adverse reaction |
Adverse reaction to drug |
Drug groups primarily affecting autonomic nervous system adverse reaction |
Adverse reaction to drug |
Drug groups primarily affecting cardiovascular system adverse reaction |
Adverse reaction to drug |
Drug groups primarily affecting central nervous system adverse reaction |
Adverse reaction to drug |
Drug groups primarily affecting gastrointestinal system adverse reaction |
Adverse reaction to drug |
Drug groups primarily affecting musculoskeletal system adverse reaction |
Adverse reaction to drug |
Drug groups primarily affecting respiratory system adverse reaction |
Adverse reaction to drug |
Drug groups primarily affecting the autonomic nervous system |
Product containing autonomic agent (product) |
Drug hypersensitivity (& [NOS]) |
Propensity to adverse reactions to drug |
Drug hypersensitivity |
Propensity to adverse reactions to drug |
Drug hypersensitivity NOS |
Propensity to adverse reactions to drug |
Drug induced rash (& ingestion dermatitis) |
Dermatitis caused by substance taken via oral route (disorder) |
Drug level in urine specimen above therapeutic range |
Urine substance level above reference range (finding) |
Drug ointment, 0,025% |
Ointment |
Drug ointment, 0,05% |
Ointment |
Drug ointment, 0,1% |
Ointment |
Drug ointment, 0,2% |
Ointment |
Drug ointment, 0,25% |
Ointment |
Drug ointment, 1% |
Ointment |
Drug ointment, 2,5% |
Ointment |
Drug reaction - CNS drug |
Adverse reaction to drug |
Drug reaction - CNS drug |
Adverse reaction to drug |
Drug reaction - CNS drug NOS |
Adverse reaction to drug |
Drug reaction - CNS drug NOS |
Adverse reaction to drug |
Drug reaction to analgesic NOS |
Analgesic adverse reaction |
Drug reaction to analgesic NOS |
Analgesic adverse reaction |
Drug specific allergen extract |
Pharmaceutical / biologic product (product) |
Drug therapy NOS |
Drug therapy (procedure) |
Drug therapy NOS |
Drug therapy (procedure) |
Drug therapy status |
Drug therapy with explicit context |
Drug withdrawal |
Substance withdrawal |
Drug withdrawal seizure |
Seizure co-occurrent and due to substance withdrawal |
Drug withdrawal syndrome |
Substance withdrawal |
Drug withdrawal syndrome |
Substance withdrawal |
Drug, medicament or biological substance |
Drug or medicament (substance) |
Drug, medicament, or biological substance in urine above reference range |
Urine substance level above reference range (finding) |
Drug-induced impotence |
Erectile dysfunction caused by drug |
Drug-induced nephrogenic diabetes insipidus |
Acquired vasopressin resistance |
Drug-related disorder |
Disease |
Drugs for guinea worms [no drugs here] |
Anthelmintic |
Drugs for hookworms |
Anthelmintic |
Drugs for the control of epilepsy |
Anticonvulsant (substance) |
Drugs for threadworms |
Anthelmintic |
Drugs for trichomonacides |
Antiprotozoal |
Drugs in urine abnormal [D] |
Substance in urine detected by screening method (finding) |
Drugs used in hyperuricemia |
Uricosuric agent (substance) |
Drugs used in infections |
Anti-infective agent (substance) |
Drugs used in malignant disease and for immunosuppression |
Immunosuppressant (substance) |